Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.100
+0.100 (10.00%)
May 20, 2025, 4:00 PM - Market closed
Predictive Oncology Revenue
Predictive Oncology had revenue of $110.31K in the quarter ending March 31, 2025, a decrease of -73.71%. This brings the company's revenue in the last twelve months to $1.73M, up 24.17% year-over-year. In the year 2024, Predictive Oncology had annual revenue of $1.62M, down -0.24%.
Revenue (ttm)
$1.73M
Revenue Growth
+24.17%
P/S Ratio
3.96
Revenue / Employee
$72,053
Employees
24
Market Cap
9.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.62M | -3.88K | -0.24% |
Dec 31, 2023 | 1.63M | 122.24K | 8.12% |
Dec 31, 2022 | 1.51M | 84.78K | 5.97% |
Dec 31, 2021 | 1.42M | 168.41K | 13.45% |
Dec 31, 2020 | 1.25M | -159.29K | -11.28% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
POAI News
- 21 hours ago - Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" - GlobeNewsWire
- 5 days ago - Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewsWire
- 2 months ago - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewsWire
- 3 months ago - Predictive Oncology Closes Registered Direct Offering - GlobeNewsWire
- 3 months ago - Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - GlobeNewsWire
- 3 months ago - Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform - Business Wire